Between Feb @ and July @ , @ , @ patients at @ investigational sites in @ countries were enrolled into the study , of whom @ were eligible and were randomly assigned to the two treatment groups ( @ to the olaparib plus chemotherapy group and @ to the chemotherapy alone group ) .